Co-Diagnostics, Inc.
CODXNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · UT · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $622,489 | $3.9M | $6.8M | $34.2M | $97.9M | $74.6M |
| Operating income | −$50.2M | −$40.1M | −$42.7M | −$27.0M | $46.1M | $41.7M |
| Net income | −$46.9M | −$37.6M | −$35.3M | −$14.2M | $36.7M | $42.5M |
| Total assets | $24.7M | $64.0M | $95.3M | $123.1M | $160.0M | $71.2M |
| Total liabilities | $4.1M | $9.7M | $9.3M | $8.6M | $25.6M | $4.5M |
| Equity | $20.6M | $54.3M | $86.0M | $114.5M | $134.5M | $66.7M |
| EPS (diluted) | $-35.25 | $-1.24 | $-1.20 | $-0.45 | $1.23 | $1.52 |
| Shares out. | 33.6M | 31.3M | 30.9M | 34.0M | 28.7M | 27.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −8058.8%
- Net margin
- −7533.6%
- Return on equity
- −227.3%
- Return on assets
- −189.5%
- Return on capital (ROCE)
- −236.6%
- Liabilities / assets
- 16.6%
- Debt / equity
- 0.20×
- Book value / share
- $0.61
- Revenue growth (YoY)
- −84.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -16.26distress
- Accruals / assets
- −71.8%clean
- Beneish M-Score
- 0.33elevated
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 5 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Beneish M-Score elevated — earnings-manipulation screen flag
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Ayrton Capital LlcPassive (13G)Feb 11, 2026
- Orca Capital AgPassive (13G)Oct 30, 2025
- Vanguard Group IncPassive (13G)Oct 30, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Egan Dwight HOfficer — Chief Executive Officer | May 23, 2026 | Grant | 4,584 | $0.00 |
| Brown Brian LeeOfficer — Chief Financial Officer | May 23, 2026 | Grant | 3,750 | $0.00 |
| Abbott Richard DavidOfficer — President | May 23, 2026 | Grant | 1,890 | $0.00 |
| Murphy Edward L.Director | May 23, 2026 | Grant | 1,695 | $0.00 |
| Serbin Richard SDirector | May 23, 2026 | Grant | 1,695 | $0.00 |
| Durenard EugeneDirector | May 23, 2026 | Grant | 1,695 | $0.00 |
| Nelson James BDirector | May 23, 2026 | Grant | 1,695 | $0.00 |
| Murphy Edward L.Director | Nov 23, 2025 | Grant | 57,499 | $0.00 |
| Brown Brian LeeOfficer — Chief Financial Officer | Nov 23, 2025 | Grant | 134,167 | $0.00 |
| Abbott Richard DavidOfficer — President | Nov 23, 2025 | Grant | 56,667 | $0.00 |
| Egan Dwight HOfficer — Chief Executive Officer | Nov 23, 2025 | Grant | 163,333 | $0.00 |
| Serbin Richard SDirector | Nov 23, 2025 | Grant | 57,499 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 194,179 | 1.0 | +104.9% |
| Apr 30, 2026 | 94,771 | 1.0 | +107.4% |
| Apr 15, 2026 | 45,702 | 1.0 | -72.9% |
| Mar 31, 2026 | 168,619 | 1.0 | +195.7% |
| Mar 13, 2026 | 57,017 | 1.0 | +795.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Unregistered equity sale · Other material eventMay 21, 2026
- Results of operations · Regulation FD disclosureMay 14, 2026
- Results of operations · Regulation FD disclosureMar 31, 2026
- Results of operations · Other material eventMar 10, 2026
- Delisting / listing-standard noticeJan 13, 2026
- Modified shareholder rights · Amended charter or bylaws · Regulation FD disclosureDec 30, 2025
- Shareholder voteDec 5, 2025
- Results of operations · Regulation FD disclosureNov 13, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- EFFECTMay 29, 2026
- S-3May 28, 2026
- 4PRIMARY DOCUMENTMay 27, 2026
- 4PRIMARY DOCUMENTMay 27, 2026
- 4PRIMARY DOCUMENTMay 27, 2026
- 4PRIMARY DOCUMENTMay 27, 2026
- 4PRIMARY DOCUMENTMay 27, 2026
- 4PRIMARY DOCUMENTMay 27, 2026
- 4PRIMARY DOCUMENTMay 27, 2026
- DRSMay 22, 2026
- 8-KMay 21, 2026
- EFFECTMay 15, 2026
- 10-QMay 14, 2026
- 8-KMay 14, 2026
- S-3May 12, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.